Comment & Controversy

Insurers are the stumbling block in a move to extended-cycle OCs

“WELCOME TO THE TIPPING POINT IN ORAL CONTRACEPTION PRESCRIBING” BY ROBERT L. BARBIERI, MD (EDITORIAL, JULY)

My thanks to Dr. Barbieri for the useful information and excellent clinical opinion he presented in his discussion of oral contraceptive regimens. I have a different answer, however, to his final question: “Why do we continue to prescribe 21-7 OCs?”